Log in
Enquire now
Bioxodes

Bioxodes

Developer of therapeutics for the prevention and treatment of thrombotic and inflammatory diseases

OverviewStructured DataIssuesContributors

Contents

bioxodes.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Engineering
Engineering
Biology
Biology
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Biomedical engineering
Biomedical engineering
Location
Marche-en-Famenne
Marche-en-Famenne
0
Gosselies
Gosselies
0
Pitchbook URL
pitchbook.com/profiles.../60517-00
Number of Employees (Ranges)
1 – 10
Email Address
info@bioxodes.com0
Full Address
PARC D'ACTIVITÉS ÉCONOMIQUES DU WEX RUE DE LA PLAINE, 11 6900 MARCHE-EN-FAMENNE, BELGIQUE0
BRUSSELS SOUTH CHARLEROI BIOPARK RUE SANTOS-DUMONT, 1 6041 GOSSELIES, BELGIQUE0
Investors
Sfpi-Fpim
Sfpi-Fpim
0
‌
Life Sciences Research Partners
0
Sambrinvest
Sambrinvest
0
Newton BioCapital
Newton BioCapital
Founded Date
2013
Total Funding Amount (USD)
12,695,160
Latest Funding Round Date
December 10, 2025
Latest Funding Type
Series A
Series A
Country
Belgium
Belgium
0
Headquarters
Charleroi
Charleroi

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
6,500,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Bioxodes

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.